Sante Tura

PHP26 CLASSIFICATION AND REGRESSION TREES HELP IN DEVELOPING EMBEDDED EVIDENCEAND CONSENSUS-BASED GUIDELINES

Monia Marchetti, Giovanni Barosi, Sante Tura, 2002 .

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Sante Tura, Thomas Fischer, Alois Gratwohl, 2002, Blood.

Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders

Maria Domenica Cappellini, Giovanni Barosi, Sante Tura, 2008, Haematologica.

A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.

Sante Tura, Giovanni Martinelli, Giuseppe Saglio, 2002, Blood.

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

Francisco Cervantes, Sante Tura, Thomas J. Braun, 1984 .

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.

Sante Tura, Michele Cavo, Patrizia Tosi, 2004, Haematologica.

Stem cell plasticity: time for a reappraisal?

Sante Tura, Fulvio Mavilio, Giuliana Ferrari, 2005, Haematologica.

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.

Sante Tura, R. Fanin, M. Baccarani, 1994, The New England journal of medicine.